FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885113334> ?p ?o ?g. }

• W2885113334 endingPage "4745" @default.
• W2885113334 startingPage "4739" @default.
• W2885113334 abstract "In patients without tissue availability at presentation, the analysis of cell-free DNA derived from liquid biopsy samples, in particular from plasma, represents an established alternative for providing epidermal growth factor receptor (EGFR) mutational testing for treatment decision-making. Compared with quantitative polymerase chain reaction and digital polymerase chain reaction-targeted methods, next-generation sequencing can provide more information about tumor molecular alterations, especially EGFR mutations. Here, we present a case of a patient with non-small cell lung cancer (NSCLC) harboring 3 uncommon mutations of EGFR-R670W in exon 17 and H833V, and H835L in exon 21, as shown by next-generation sequencing of plasma cell-free DNA. To the best of our knowledge, this is the first case report of a patient harboring the R670W mutation. The patient responded well to second-generation tyrosine kinase inhibitors (TKIs). T790M is an acquired resistant mutation in patients with R670W, H833V, and H835L. This is also the first case of a patient harboring the H833V/H835L/T790M triple mutation; the patient had a good response to the third-generation TKI osimertinib. In this work, we also performed a literature review on the clinical characteristics of NSCLC patients with the H833V/H835L double mutation, together with a descriptive analysis about their response to EGFR TKI monotherapy as a first-line treatment, according to data from previous case reports. The results showed that the cohort of NSCLC patients with H833V/H835L responded well to EGFR TKIs; thus, before treatment in clinical practice, screening for EGFR mutations should be conducted and EGFR TKIs should be preferred in NSCLC patients with H833V/H835L mutations." @default.
• W2885113334 created "2018-08-22" @default.
• W2885113334 creator A5015766629 @default.
• W2885113334 creator A5020286464 @default.
• W2885113334 creator A5021579154 @default.
• W2885113334 creator A5051115329 @default.
• W2885113334 creator A5052382834 @default.
• W2885113334 creator A5058391979 @default.
• W2885113334 creator A5088379158 @default.
• W2885113334 date "2018-08-01" @default.
• W2885113334 modified "2023-10-14" @default.
• W2885113334 title "The effectiveness of afatinib and osimertinib in a Chinese patient with advanced lung adenocarcinoma harboring a rare triple EGFR mutation (R670W/H835L/L833V): a case report and literature review" @default.
• W2885113334 cites W2019367228 @default.
• W2885113334 cites W2040299716 @default.
• W2885113334 cites W2062629045 @default.
• W2885113334 cites W2103551452 @default.
• W2885113334 cites W2139804581 @default.
• W2885113334 cites W2140832617 @default.
• W2885113334 cites W2147703884 @default.
• W2885113334 cites W2263144737 @default.
• W2885113334 cites W2345182163 @default.
• W2885113334 cites W2465430906 @default.
• W2885113334 cites W2560717039 @default.
• W2885113334 cites W2609723037 @default.
• W2885113334 cites W2769659311 @default.
• W2885113334 cites W2773258191 @default.
• W2885113334 cites W2776194348 @default.
• W2885113334 cites W1853526923 @default.
• W2885113334 doi "https://doi.org/10.2147/ott.s167346" @default.
• W2885113334 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6091473" @default.
• W2885113334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30127622" @default.
• W2885113334 hasPublicationYear "2018" @default.
• W2885113334 type Work @default.
• W2885113334 sameAs 2885113334 @default.
• W2885113334 citedByCount "21" @default.
• W2885113334 countsByYear W28851133342019 @default.
• W2885113334 countsByYear W28851133342020 @default.
• W2885113334 countsByYear W28851133342021 @default.
• W2885113334 countsByYear W28851133342022 @default.
• W2885113334 countsByYear W28851133342023 @default.
• W2885113334 crossrefType "journal-article" @default.
• W2885113334 hasAuthorship W2885113334A5015766629 @default.
• W2885113334 hasAuthorship W2885113334A5020286464 @default.
• W2885113334 hasAuthorship W2885113334A5021579154 @default.
• W2885113334 hasAuthorship W2885113334A5051115329 @default.
• W2885113334 hasAuthorship W2885113334A5052382834 @default.
• W2885113334 hasAuthorship W2885113334A5058391979 @default.
• W2885113334 hasAuthorship W2885113334A5088379158 @default.
• W2885113334 hasBestOaLocation W28851133341 @default.
• W2885113334 hasConcept C104317684 @default.
• W2885113334 hasConcept C121608353 @default.
• W2885113334 hasConcept C126322002 @default.
• W2885113334 hasConcept C143998085 @default.
• W2885113334 hasConcept C2776256026 @default.
• W2885113334 hasConcept C2777626846 @default.
• W2885113334 hasConcept C2777930144 @default.
• W2885113334 hasConcept C2778087573 @default.
• W2885113334 hasConcept C2779438470 @default.
• W2885113334 hasConcept C2779529041 @default.
• W2885113334 hasConcept C2780580887 @default.
• W2885113334 hasConcept C2780586478 @default.
• W2885113334 hasConcept C2781182431 @default.
• W2885113334 hasConcept C2781230642 @default.
• W2885113334 hasConcept C36823959 @default.
• W2885113334 hasConcept C48126324 @default.
• W2885113334 hasConcept C49105822 @default.
• W2885113334 hasConcept C501734568 @default.
• W2885113334 hasConcept C502942594 @default.
• W2885113334 hasConcept C54355233 @default.
• W2885113334 hasConcept C71924100 @default.
• W2885113334 hasConcept C86803240 @default.
• W2885113334 hasConceptScore W2885113334C104317684 @default.
• W2885113334 hasConceptScore W2885113334C121608353 @default.
• W2885113334 hasConceptScore W2885113334C126322002 @default.
• W2885113334 hasConceptScore W2885113334C143998085 @default.
• W2885113334 hasConceptScore W2885113334C2776256026 @default.
• W2885113334 hasConceptScore W2885113334C2777626846 @default.
• W2885113334 hasConceptScore W2885113334C2777930144 @default.
• W2885113334 hasConceptScore W2885113334C2778087573 @default.
• W2885113334 hasConceptScore W2885113334C2779438470 @default.
• W2885113334 hasConceptScore W2885113334C2779529041 @default.
• W2885113334 hasConceptScore W2885113334C2780580887 @default.
• W2885113334 hasConceptScore W2885113334C2780586478 @default.
• W2885113334 hasConceptScore W2885113334C2781182431 @default.
• W2885113334 hasConceptScore W2885113334C2781230642 @default.
• W2885113334 hasConceptScore W2885113334C36823959 @default.
• W2885113334 hasConceptScore W2885113334C48126324 @default.
• W2885113334 hasConceptScore W2885113334C49105822 @default.
• W2885113334 hasConceptScore W2885113334C501734568 @default.
• W2885113334 hasConceptScore W2885113334C502942594 @default.
• W2885113334 hasConceptScore W2885113334C54355233 @default.
• W2885113334 hasConceptScore W2885113334C71924100 @default.
• W2885113334 hasConceptScore W2885113334C86803240 @default.
• W2885113334 hasLocation W28851133341 @default.
• W2885113334 hasLocation W28851133342 @default.
• W2885113334 hasLocation W28851133343 @default.
• W2885113334 hasLocation W28851133344 @default.
• W2885113334 hasOpenAccess W2885113334 @default.

• next